INVESTING INSIGHTS & ANALYSIS
Below is an archive of our professional insight and analysis that will help you unlock the wealth building power of private equity and early-stage investing.
How to Value Pre-IPO Companies
And why 2022 could change valuations for the better…
What $100 Oil Could Mean for Sky Quarry
The best performing asset class of 2021 could mean a lot. Here’s why…
Surgical Robots: Overhyped or Breakthrough Tech?
What every MedTech investor needs to know about surgical robots
Investing When Markets Go Haywire
What to do when things get a little crazy…
Jake’s 2022 Predictions
A look at the year past and the year forward. Are you ready for what’s to come?
The Key to Growing MedTech Companies
What investors need to know about how medical devices are marketed.
How to Value Pre-IPO Companies
And why 2022 could change valuations for the better…
What $100 Oil Could Mean for Sky Quarry
The best performing asset class of 2021 could mean a lot. Here’s why…
Surgical Robots: Overhyped or Breakthrough Tech?
What every MedTech investor needs to know about surgical robots
Investing When Markets Go Haywire
What to do when things get a little crazy…
How ESG Creates Shareholder Value
For decades, ESG investing was code for “lower returns” or “cheap marketing gimmick”. But now?
Jake’s 2022 Predictions
A look at the year past and the year forward. Are you ready for what’s to come?
Don't make another private market investment without reading this...
The 5 Mistakes
investors make that crush returns
Download this free report now:
Just enter your name & email to access this report for free.
By submitting your email address you will receive access to this report and a free subscription to Equifund’s private investment newsletter. You can unsubscribe at any time and read more about our privacy policy here.
Advertisement:
Assure Health
- Personalized care that keeps seniors safe and healthy from home
Investment Highlights:
- 1
First-to-market remote patient care and telehealth platform that offers daily monitoring of qualified Medicare patients at no out-of-pocket cost.
- 2
Potential path to becoming a $1 billion company at current public market multiples.
- 3
Skyrocketing virtual medicine adoption rates -- especially among seniors -- thanks to COVID-19.
